CRMT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient investor: the chart trend is still bearish (SMA_200 > SMA_20 > SMA_5, MACD below zero) and fundamentals just deteriorated sharply (large net loss in 2026/Q2).", "Risk/reward is skewed negative near-term due to active class-action/law-firm investigations and the next earnings catalyst on 2026-03-05 (pre-market), which can reintroduce downside volatility.", "If trading tactically, the only constructive setup would be a quick bounce trade holding above S1 (24.73) and reclaiming pivot (26.39) with strength toward R1 (~28.05), but this is not supported by Intellectia signals today.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Trend: Bearish structure with moving averages stacked down (SMA_200 > SMA_20 > SMA_5) despite today\u2019s +5.84% pop to 26.28\u2014suggests a rebound inside a broader downtrend.", "Momentum: MACD histogram at -0.33 (below 0) and negatively contracting\u2014bearish momentum is easing, but not reversed.", "RSI: RSI_6 ~44.2 (neutral) \u2014 no oversold signal that would strongly favor an immediate dip-buy.", "Key levels: Pivot 26.387 (price ~26.28 slightly below), resistance R1 28.047 then R2 29.073; support S1 24.728 then S2 23.702.", "Pattern-based projection (similar candlesticks): 70% chance of +2.06% next day; +8.67% next week; +4.14% next month \u2014 modest upside probabilities, but not strong enough to override bearish trend/earnings risk."]
and pushes toward 28\u201329 resistance zone."]
regarding investigations/preparing class action tied to alleged misleading information\u2014headline/legal overhang is a clear sentiment drag.", "Recent sharp drawdown context: stock fell ~18.2% after a first-quarter loss report (per news summary), indicating fragile investor confidence.", "Upcoming earnings (2026-03-05 pre-market) is a binary catalyst; given recent losses, market may demand clearer evidence of stabilization."]
["Latest quarter: 2026/Q2.", "Revenue: 350.192M, up +0.84% YoY (low growth).", "Profitability deteriorated materially: Net income -22.482M (down -541.78% YoY) and EPS -2.71 (down -544.26% YoY).", "Gross margin: 48.28%, down -2.60% YoY \u2014 margin compression alongside losses suggests operational/credit pressure remains meaningful."]
["Most recent update (2025-12-29, Jefferies): Hold rating maintained; price target cut to $29 from $34.", "Interpretation: Wall Street view is cautious/neutral\u2014acknowledges balance-sheet focus and some operational positives (cost savings, margins, lower delinquencies), but the lowered target signals reduced confidence in near-term upside.", "At today\u2019s price (26.28), the $29 target implies limited upside (~10%), which is not compelling given litigation headlines and weak recent earnings trajectory."]
